TABLE 1

Distribution of patients between inhaled corticosteroid (ICS) and non-ICS groups by baseline characteristics

OverallNon-ICS groupICS group
Patients947543715104
Age, years69.7±10.070.0±9.769.4±10.2
Female4111 (43.4)1809 (41.4)2302 (45.1)
Current smoker#3946 (41.8)1836 (42.1)2110 (41.6)
Airflow limitation severity (most recent FEV1% predicted)
 Mild (≥80%)838 (11.9)401 (11.3)437 (12.5)
 Moderate (50–80%)3878 (55.0)2110 (59.4)1768 (50.6)
 Severe (30–50%)2010 (28.5)914 (25.7)1096 (31.4)
 Very severe (<30%)322 (4.6)127 (3.6)195 (5.6)
Asthma >2 years previously1098 (11.6)269 (6.2)829 (16.2)
History of atopy+2493 (26.3)1107 (25.3)1386 (27.2)
Exacerbations in previous year
 04887 (51.6)2433 (55.7)2454 (48.1)
 12829 (29.9)1250 (28.6)1579 (30.9)
 21165 (12.3)466 (10.7)699 (13.7)
 ⩾3594 (6.3)222 (5.1)372 (7.3)
Pneumonia episodes in previous year
 07484 (79.0)3514 (80.4)3970 (77.8)
 11500 (15.8)660 (15.1)840 (16.5)
 ⩾2491 (5.2)197 (4.5)294 (5.8)
Theophylline in previous 2years97 (1.0)17 (0.4)80 (1.6)
Oxygen use ever46 (0.5)19 (0.4)27 (0.5)
Nebulisers in previous 2years157 (1.7)48 (1.1)109 (2.1)
Nonelective hospitalisations§ in previous year
 07767 (82.0)3663 (83.8)4104 (80.4)
 11277 (13.5)529 (12.1)748 (14.7)
 ⩾2431 (4.6)179 (4.1)252 (4.9)
GP consultations in previous year
 0–32699 (28.5)1280 (29.3)1419 (27.8)
 4–73381 (35.7)1586 (36.3)1795 (35.2)
 ⩾83395 (35.8)1505 (34.4)1890 (37.0)
Influenza vaccination in previous year6710 (70.8)3106 (71.1)3604 (70.6)
Blood eosinophil count (cells·µL−1)
 Geometric mean200200201
 Median (IQR)200 (100–300)200 (100–300)200 (100–300)

Data are presented as n, mean±sd or n (%), unless otherwise stated. Percentages are column percentages. FEV1: forced expiratory volume in 1 s; GP: general practitioner; IQR: interquartile range. #: n=9442 for smoking status (only past or current smokers included); : n=7048 for airflow limitation severity; +: atopy defined using presence of codes for allergy, eczema or hay fever; §: for any cause.